Percutaneous cryoablation of abdominal wall endometriosis: a systematic literature review of safety and efficacy.

IF 4.1 2区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Insights into Imaging Pub Date : 2024-11-22 DOI:10.1186/s13244-024-01823-4

Sylvain Bodard, Leo Razakamanantsoa, Ruben Geevarghese, Julianne O'Gorman, Anthony Dohan, Clement Marcelin, François H Cornelis

{"title":"Percutaneous cryoablation of abdominal wall endometriosis: a systematic literature review of safety and efficacy.","authors":"Sylvain Bodard, Leo Razakamanantsoa, Ruben Geevarghese, Julianne O'Gorman, Anthony Dohan, Clement Marcelin, François H Cornelis","doi":"10.1186/s13244-024-01823-4","DOIUrl":null,"url":null,"abstract":"Purpose: To investigate over 10 years the safety and efficacy of percutaneous cryoablation for the treatment of abdominal wall endometriosis (AWE).Methods: A systematic review was conducted of literature published between March 2014 and March 2024. Inclusion criteria focused on treatment efficacy studies, while exclusion criteria targeted case reports and studies lacking pertinent outcome data. Methodological quality was assessed using the Newcastle-Ottawa Scale for cohort studies.Results: A total of eight studies were included. Local pain scores decreased from a median of 8/10 (interquartile range (IQR) 7-9) on the visual analog scale to 1/10 (IQR 0-2) at the last follow-up (p < 0.0001). Median complete local pain response rates ranged from 80% to 100%, with median local pain-free survival rates reaching 76.8% (IQR 55.3-83.8) at the longest follow-up. Notably, no patient reported a post-procedure pain score higher than that they reported pre-cryoablation. The studies indicated minor complications in 3.5 to 11% of cases, with major complications occurring in less than 2% of cases, graded following the guidelines of the Society of Interventional Radiology.Conclusion: In the last decade, percutaneous image-guided cryoablation has offered consistent results and appears to be a promising, minimally invasive option for AWE treatment. Prospective trials are now essential to establish cryoablation as a new standard in patient care for AWE.Critical relevance statement: Over a decade-long study, percutaneous cryoablation has proven to be a safe and effective minimally invasive treatment for abdominal wall endometriosis, significantly reducing pain with minimal complications.Key points: Percutaneous cryoablation significantly reduced local pain scores for abdominal wall endometriosis. The procedure demonstrated a favorable safety profile with minor complications. Cryoablation has emerged as a minimally invasive alternative to traditional treatments.","PeriodicalId":13639,"journal":{"name":"Insights into Imaging","volume":"15 1","pages":"282"},"PeriodicalIF":4.1000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584811/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Insights into Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13244-024-01823-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To investigate over 10 years the safety and efficacy of percutaneous cryoablation for the treatment of abdominal wall endometriosis (AWE).

Methods: A systematic review was conducted of literature published between March 2014 and March 2024. Inclusion criteria focused on treatment efficacy studies, while exclusion criteria targeted case reports and studies lacking pertinent outcome data. Methodological quality was assessed using the Newcastle-Ottawa Scale for cohort studies.

Results: A total of eight studies were included. Local pain scores decreased from a median of 8/10 (interquartile range (IQR) 7-9) on the visual analog scale to 1/10 (IQR 0-2) at the last follow-up (p < 0.0001). Median complete local pain response rates ranged from 80% to 100%, with median local pain-free survival rates reaching 76.8% (IQR 55.3-83.8) at the longest follow-up. Notably, no patient reported a post-procedure pain score higher than that they reported pre-cryoablation. The studies indicated minor complications in 3.5 to 11% of cases, with major complications occurring in less than 2% of cases, graded following the guidelines of the Society of Interventional Radiology.

Conclusion: In the last decade, percutaneous image-guided cryoablation has offered consistent results and appears to be a promising, minimally invasive option for AWE treatment. Prospective trials are now essential to establish cryoablation as a new standard in patient care for AWE.

Critical relevance statement: Over a decade-long study, percutaneous cryoablation has proven to be a safe and effective minimally invasive treatment for abdominal wall endometriosis, significantly reducing pain with minimal complications.

Key points: Percutaneous cryoablation significantly reduced local pain scores for abdominal wall endometriosis. The procedure demonstrated a favorable safety profile with minor complications. Cryoablation has emerged as a minimally invasive alternative to traditional treatments.

查看原文本刊更多论文

腹壁子宫内膜异位症经皮冷冻消融术：安全性和有效性的系统性文献综述。

目的：研究经皮冷冻消融术治疗腹壁子宫内膜异位症（AWE）10 年来的安全性和有效性：方法：对2014年3月至2024年3月期间发表的文献进行系统回顾。纳入标准侧重于疗效研究，而排除标准则针对病例报告和缺乏相关结果数据的研究。方法学质量采用纽卡斯尔-渥太华队列研究量表进行评估：结果：共纳入八项研究。局部疼痛评分从视觉模拟量表的中位数8/10（四分位间距（IQR）7-9）降至最后一次随访时的1/10（IQR 0-2）（p 结论：在过去的十年中，经皮穿刺术已成为一种有效的治疗方法：在过去的十年中，经皮图像引导冷冻消融术取得了一致的疗效，似乎是治疗 AWE 的一种很有前景的微创选择。前瞻性试验对于将冷冻消融术确立为 AWE 患者治疗的新标准至关重要：在长达十年的研究中，经皮冷冻消融术已被证明是治疗腹壁子宫内膜异位症的一种安全有效的微创疗法，可显著减轻疼痛，并发症极少：要点：经皮冷冻消融术可明显减轻腹壁子宫内膜异位症的局部疼痛评分。要点：经皮冷冻消融术可明显减轻腹壁子宫内膜异位症的局部疼痛评分，手术安全性良好，并发症少。冷冻消融术已成为传统疗法的微创替代疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Insights into Imaging Medicine-Radiology, Nuclear Medicine and Imaging

CiteScore

7.30

自引率

4.30%

发文量

182

审稿时长

13 weeks

期刊介绍： Insights into Imaging (I³) is a peer-reviewed open access journal published under the brand SpringerOpen. All content published in the journal is freely available online to anyone, anywhere! I³ continuously updates scientific knowledge and progress in best-practice standards in radiology through the publication of original articles and state-of-the-art reviews and opinions, along with recommendations and statements from the leading radiological societies in Europe. Founded by the European Society of Radiology (ESR), I³ creates a platform for educational material, guidelines and recommendations, and a forum for topics of controversy. A balanced combination of review articles, original papers, short communications from European radiological congresses and information on society matters makes I³ an indispensable source for current information in this field. I³ is owned by the ESR, however authors retain copyright to their article according to the Creative Commons Attribution License (see Copyright and License Agreement). All articles can be read, redistributed and reused for free, as long as the author of the original work is cited properly. The open access fees (article-processing charges) for this journal are kindly sponsored by ESR for all Members. The journal went open access in 2012, which means that all articles published since then are freely available online.